273 related articles for article (PubMed ID: 28669104)
41. The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer.
Knittelfelder O; Delago D; Jakse G; Reinisch S; Partl R; Stranzl-Lawatsch H; Renner W; Langsenlehner T
Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33228184
[TBL] [Abstract][Full Text] [Related]
42. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients.
Drácz B; Czompa D; Müllner K; Hagymási K; Miheller P; Székely H; Papp V; Horváth M; Hritz I; Szijártó A; Werling K
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366457
[TBL] [Abstract][Full Text] [Related]
43. De Ritis Ratio as a Significant Prognostic Factor in Patients with Sepsis: A Retrospective Analysis.
Zhao PY; Yao RQ; Ren C; Li SY; Li YX; Zhu SY; Yao YM; Du XH
J Surg Res; 2021 Aug; 264():375-385. PubMed ID: 33848836
[TBL] [Abstract][Full Text] [Related]
44. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
[TBL] [Abstract][Full Text] [Related]
45. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
[TBL] [Abstract][Full Text] [Related]
46. The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Jo JK; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
Int Urol Nephrol; 2016 Apr; 48(4):489-94. PubMed ID: 26810322
[TBL] [Abstract][Full Text] [Related]
47. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
48. Decrease of Preoperative Serum Albumin-to-Globulin Ratio as a Prognostic Indicator after Radical Cystectomy in Patients with Urothelial Bladder Cancer.
Oh JS; Park DJ; Byeon KH; Ha YS; Kim TH; Yoo ES; Kwon TG; Kim HT
Urol J; 2021 Jan; 18(1):66-73. PubMed ID: 33515214
[TBL] [Abstract][Full Text] [Related]
49. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.
Boström PJ; Alkhateeb S; Trottier G; Athanasopoulos PZ; Mirtti T; Kortekangas H; Laato M; van Rhijn B; van der Kwast T; Fleshner NE; Jewett MA; Finelli A; Zlotta AR
BJU Int; 2012 Jan; 109(1):70-6. PubMed ID: 21851540
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
Schulz GB; Grimm T; Buchner A; Jokisch F; Grabbert M; Schneevoigt BS; Kretschmer A; Stief CG; Karl A
Clin Genitourin Cancer; 2017 Dec; 15(6):e915-e921. PubMed ID: 28587816
[TBL] [Abstract][Full Text] [Related]
51. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
52. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.
Mori K; Miura N; Mostafaei H; Quhal F; Motlagh RS; Lysenko I; Kimura S; Egawa S; Karakiewicz PI; Shariat SF
Int J Clin Oncol; 2020 Aug; 25(8):1459-1474. PubMed ID: 32451768
[TBL] [Abstract][Full Text] [Related]
54. ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
D'Andrea D; Moschini M; Soria F; Gust KM; Briganti A; Karakiewicz PI; Rouprêt M; Shariat SF
Anticancer Res; 2017 Oct; 37(10):5747-5753. PubMed ID: 28982896
[TBL] [Abstract][Full Text] [Related]
55. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
Yin G; Man C; Liao S; Qiu H
Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
[TBL] [Abstract][Full Text] [Related]
56. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
[TBL] [Abstract][Full Text] [Related]
57. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR
BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341
[TBL] [Abstract][Full Text] [Related]
58. Does patient age affect survival after radical cystectomy?
Horovitz D; Turker P; Bostrom PJ; Mirtti T; Nurmi M; Kuk C; Kulkarni G; Fleshner NE; Finelli A; Jewett MA; Zlotta AR
BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360
[TBL] [Abstract][Full Text] [Related]
59. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
[TBL] [Abstract][Full Text] [Related]
60. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]